Comparison between a bid and a tid regimen: Improved compliance with no improved antihypertensive effect

European Journal of Clinical Pharmacology

Volumn 50, Issue 1-2, 1996, Pages 63-67

  Boissel, J P ^a   Meillard, O ^b   Perrin Fayolle, E ^a   Ducruet, T ^a   Alamercery, Y ^a   Sassano, P ^b   Benghozi, R ^b  

^a RCTs   (France)

^b SANDOZ   (France)

Author keywords

Compliance; Hypertension; Multicentre study; Nicardipine; Slow release formulation

Indexed keywords

NICARDIPINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NICARDIPINE; PATIENT COMPLIANCE; TREATMENT REFUSAL;

EID: 0029922432     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050070     Document Type: Article

References (16)

1. Haynes RB, Taylor DW, Sackett DL (1979) Compliance in Health Care. The John Hopkins University Press Baltimore
2. Urquhart J, Chevalley C (1988) Impact of urecognized dosing errors on the cost and effectiveness of pharmaceuticals. Drug Inf J 22:363-378
3. Clinite JC, Kabat HF (1969) Prescribed drugs: errors during self-administration. JAMA 9:450-452
4. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL (1989) How often is medication taken as prescribed? A novel assessment technique. JAMA 261:3273-3277
5. Cramer JA, Spilker B (1991) Patient compliance in medical practice and clinical trials. Raven Press New York
6. Shulman N, Cutter G, Daugherty R, Sexton M, Pauk G, Taylor MJ, Tyler M (1982) Correlates of attendance and compliance in the hypertension detection and follow-up program. Control Clin Trials 3:13-27
7. Caldwell JR, Cobb S, Dowling MD, De Jongh D (1970) The drop out problem in antihypertensive treatment: a pilot study of social and emotional factors influencing a patient ability to follow antihypertensive treatment. J Chron Dis 22:579-592
8. Lowenthal DT, Briggs WA, Mutterperl R, Adelman B, Creditor MA (1976) Patient compliance for antihypertensive medication: the usefulness of urine assays. Cur Ther Res 19:405-409
9. Burris JF, Weir MR, Oparil S, Weber M, Cady WJ. Steward WH (1990) An assessment of diltiazem and hydrochlorothiazide in hypertension: application of factorial trial design to a multicentre clinical trial of combination therapy. JAMA 263: 1507-1512
10. Ayd FJ (1974) Single daily dose of antidepressants. JAMA 230:263-264
11. Taggart AJ, Johnston GD, McDevitt DG (1981) Does the frequency of daily dosage influence compliance with digoxin therapy? Br J Clin Pharmacol 1:31-34
12. Cockburn J, Reid L, Bowman JA. Sanson-Fisher RW (1987) Effects of intervention on antibiotic compliance in patients in general practice. Med J Australia 147:324-328
13. Reference deleted
14. Taylor SH, Frais MA, Lee P, Verma SP, Jackson N, Silke B (1985) Anti-hypertensive Dose-Response Effects of Nicardipine in Stable Essential Hypertension. Br J Clin Pharmacol 20: 135S-138S
15. Dow RJ, Graham DJM (1986) A review of the human metabolism and pharmacokinetics of nicardipine hydrochloride. Br J Clin Pharmacol 22:195S-202S
16. Levy G (1993) A pharmacokinetic perspective on medicament non compliance. Clin Pharm Ther 54:242-244